Polycystic ovary syndrome: A biopsychosocial understanding in young women to improve knowledge and treatment options

Journal of Psychosomatic Obstetrics and Gynecology

Volumn 31, Issue 1, 2010, Pages 24-31

  Moran, Lisa ^a   Gibson Helm, Melanie ^a   Teede, Helena ^a,b   Deeks, Amanda ^a  

^a MONASH UNIVERSITY   (Australia)

^b Diabetes Unit   (Australia)

Author keywords

Endocrinology; Polycystic ovary syndrome; Psychological wellbeing; Women's health

Indexed keywords

ADULT; AGE DISTRIBUTION; ANXIETY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FEAR; FEMALE; FEMALE INFERTILITY; FEMININITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; PATIENT ATTITUDE; PREGNANCY DIABETES MELLITUS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RISK ASSESSMENT; SEXUALITY; WEIGHT GAIN;

ADULT; ANXIETY; AUSTRALIA; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFERTILITY, FEMALE; OBESITY; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; QUALITY OF LIFE; RISK FACTORS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 77149146813     PISSN: 0167482X     EISSN: 17438942     Source Type: Journal    
DOI: 10.3109/01674820903477593     Document Type: Article

References (36)

1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006-4011.
2. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008;93:1276-1284.
3. Norman RJ, Masters L, Milner CR, Wang JX, Davies MJ. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 2001;16:1995-1998.
4. Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.[see comment]. J Clin Endocrinol Metab 2006;91:492-497.
5. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:1017-1023.
6. Jones GL, Balen AH, Ledger WL. Health-related quality of life in PCOS and related infertility: how can we assess this? Hum Fertil (Cambridge, England) 2008;11:173-185.
7. Himelein MJ, Thatcher SS. Depression and body image among women with polycystic ovary syndrome. J Health Psychol 2006;11:613-625.
8. Wilhelm K, Mitchell P, Slade T, Brownhill S, Andrews G. Prevalence and correlates of DSM-IV major depression in an Australian national survey. J Affect Disord 2003;75:155-162.
9. Organisation WH. Mental health aspects of women's reproductive health. Geneva: World Health Organisation; 2009.
10. Trent ME, Rich M, Austin SB, Gordon CM. Quality of life in adolescent girls with polycystic ovary syndrome. Arch Pediatr Adolesc Med 2002;156:556-560.
11. Dramusic V, Goh VH, Rajan U, Wong YC, Ratnam SS. Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents. J Pediatr Adolesc Gynecol 1997;10:125-132.
12. Laggari V, Diareme S, Christogiorgos S, Deligeoroglou E, Christopoulos P, Tsiantis J, Creatsas G. Anxiety and depression in adolescents with polycystic ovary syndrome and Mayer-Rokitansky-Kuster-Hauser syndrome. J Psychosom Obstet Gynaecol 2009;30:83-88.
13. Klinke A, Renn O. A new approach to risk evaluation and management: risk-based, precaution-based, and discoursebased strategies. Risk Anal 2002;22:1071-1094.
14. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
15. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
16. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995;10:2107-2111.
17. Laitinen J, Taponen S, Martikainen H, Pouta A, Millwood I, Hartikainen AL, Ruokonen A, Sovio U, McCarthy MI, Franks S, et al. Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. Int J Obes Relat Metab Disord 2003;27:710-715.
18. Rich-Edwards JW, Goldman MB, Willett WC, Hunter DJ, Stampfer MJ, Colditz GA, Manson JE, Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol 1994;171:171-177.
19. Ching HL, Burke V, Stuckey BG. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin Endocrinol (Oxf) 2007;66:373-379.
20. Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M, Kimmig R, Benson S, Balamitsa E, Elsenbruch S. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol 2005;153:853-860.
21. Pekhlivanov B, Kolarov G, Kavurdzhikova S, Stoikov S. [Determinants of health related quality of life in women with polycystic ovary syndrome]. Akusherstvo i ginekologiia 2006;45:29-34.
22. Trent M, Austin SB, Rich M, Gordon CM, Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr 2005; 5:107-111.
23. Stunkard AJ, Faith MS, Allison KC. Depression and obesity. Biological Psychiatr 2003;54:330-337.
24. Stice E, Hayward C, Cameron RP, Killen JD, Taylor CB. Body-image and eating disturbances predict onset of depression among female adolescents: a longitudinal study. J Abnorm Psychol 2000;109:438-444.
25. Weiner CL, Primeau M, Ehrmann DA. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med 2004;66:356-362.
26. Trent ME, Rich M, Austin SB, Gordon CM. Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome: implications for quality of life. J Pediatr Adolesc Gynecol 2003;16:33-37.
27. Benson S, Hahn S, Tan S, Mann K, Janssen OE, Schedlowski M, Elsenbruch S. Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany. Hum Reprod 2009;24: 1446-1451.
28. Sills ES, Perloe M, Tucker MJ, Kaplan CR, Genton MG, Schattman GL. Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential selfreports. BMC Women's Health 2001;1:3.
29. Clayton WJ, Lipton M, Elford J, Rustin M, Sherr L. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol 2005;152:986-992.
30. Cussons AJ, Stuckey BG, Walsh JP, Burke V, Norman RJ. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol (Oxf) 2005;62:289-295.
31. Moran LJ, Noakes M, Clifton PM, Wittert GA, Williams G, Norman RJ. Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome. Am J Clin Nutr 2006;84: 77-87.
32. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: a position statement of the androgen excess and polycystic ovary syndrome society. Fertil Steril 2008 Dec 3.
33. Humphreys L, Costarelli V. Implementation of dietary and general lifestyle advice among women with polycystic ovarian syndrome. J R Soc Health 2008;128:190-195.
34. Moore SM, Prior KN, Bond MJ. The contributions of psychological disposition and risk factor status to health following treatment for coronary artery disease. Eur J Cardiovasc Nurs 2007;6:137-145.
35. Australian Institute of Health and Welfare. Heart, stroke and vascular diseases - Australian facts 2004. AIHW Cat. No.CVD 27. In: AIHW and National Heart Foundation of Australia (Cardiovascular Disease Series No. 22), editor. Canberra, 2004.
36. Ortendahl M. Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis. Ther Clin Risk Manag 2007;3:1175-1180.